Xinyi Chen

Also affiliated with First Affiliated Hospital of Zhengzhou University

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs”.

Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs

Chemical Communications(2020)10.1039/d0cc03243c

N/A

0DataRank · unranked

120 citations

Wei Jia, Lisa Zhao, Xinyi Chen, Guangrong Zheng, Xuan Zhang +2 more

Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor

Molecular Therapy — Oncolytics(2020)10.1016/j.omto.2020.08.017

N/A

0DataRank · unranked

76 citations

Olivia Nusbaum, Xinyi Chen, Yong Zhu, Rui Han

Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications

Scientific Reports(2021)10.1038/s41598-021-81620-x

N/A

0DataRank · unranked

55 citations

Ya Li, Rui Han, Alan Fu, Ronghua Wang, Olivia Nusbaum +5 more